alendronate has been researched along with chitosan in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 3 (23.08) | 2.80 |
Authors | Studies |
---|---|
Atilla Hincal, A; Calis, S; Samdancioglu, S; Sumnu, M | 1 |
Ochiuz, L; Peris, JE | 1 |
Baek, JS; Cho, CW; Hwang, JS; Kim, YR; Kwon, HH; Lee, JM; Shin, SC; Sung, HC | 1 |
Ha, DH; Han, HK; Shin, HJ | 1 |
Chung, JY; Kim, SE; Lee, DW; Lee, JY; Park, K; Suh, DH; Yun, YP | 1 |
Hong, KS; Jung, HS; Kim, SH; Park, JK; Seo, YK | 1 |
Chen, YC; Chiu, CC; Ho, HO; Sheu, MT | 1 |
Dash, BC; Ling, J; Liu, G; Ruan, J; Wu, H; Xu, Y; Zhang, C | 1 |
Chai, JH; Choi, TH; Choy, YB; Hur, W; Kim, MH; Kim, S; Kim, SN; Lee, JY; Lee, SH; Lee, SJ; Min, HJ; Min, HS; Park, CG; Park, M | 1 |
Hu, Y; Lei, P; Liu, G; Liu, H; Niu, W; Ruan, J; Shrike Zhang, Y; Wu, H; Xie, J; Yang, J; Zhang, C; Zhang, L | 1 |
Dolatyar, B; Doosti-Telgerd, M; Moradikhah, F; Seyedjafari, E; Shabani, I; Soheili, S | 1 |
Huang, G; Li, B; Ma, Z; Qin, S | 1 |
Bian, L; Dai, Y; Lu, X; Shi, W; Tang, H; Wang, Q; Wang, Z; Yu, S; Zhang, X; Zhang, Z; Zhao, P; Zhou, Y | 1 |
13 other study(ies) available for alendronate and chitosan
Article | Year |
---|---|
Formulation and in vitro evaluation of bisphosphonate loaded microspheres for implantation in osteolysis.
Topics: Alendronate; Bone Density Conservation Agents; Chemistry, Pharmaceutical; Chitosan; Drug Implants; Emulsions; Lactic Acid; Microspheres; Osteolysis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Solvents; Surface Properties | 2006 |
Preparation and characterisation of alendronate-loaded chitosan microparticles obtained through the spray drying technique.
Topics: Alendronate; Biological Availability; Calorimetry, Differential Scanning; Chitosan; Drug Carriers; Humans; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Microspheres; Particle Size; Spectrophotometry, Infrared; Surface Properties; Thermogravimetry | 2009 |
Alendronate-loaded microparticles for improvement of intestinal cellular absorption.
Topics: Acrylic Resins; Alendronate; Biological Availability; Bone Density Conservation Agents; Caco-2 Cells; Chitosan; Drug Carriers; Humans; Inflammation; Intestinal Absorption; Microspheres; Permeability; Stomach | 2011 |
Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.
Topics: Adhesiveness; Administration, Oral; Alendronate; Animals; Biological Availability; Bone Density Conservation Agents; Caco-2 Cells; Chemistry, Pharmaceutical; Chitosan; Drug Stability; Humans; Intestinal Absorption; Intestinal Mucosa; Lipids; Liposomes; Male; Mucins; Nanoparticles; Particle Size; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Technology, Pharmaceutical | 2012 |
Local delivery of alendronate eluting chitosan scaffold can effectively increase osteoblast functions and inhibit osteoclast differentiation.
Topics: Acid Phosphatase; Alendronate; Animals; Base Sequence; Bone Density Conservation Agents; Cell Differentiation; Cell Line; Chitosan; DNA Primers; Drug Carriers; Isoenzymes; Mice; Microscopy, Electron, Scanning; NFATC Transcription Factors; Osteoblasts; Osteoclasts; Real-Time Polymerase Chain Reaction; RNA, Messenger; Tartrate-Resistant Acid Phosphatase | 2012 |
Immobilization of BMP-2 on a nano-hydroxyapatite-coated titanium surface using a chitosan calcium chelating agent.
Topics: Alendronate; Bone Morphogenetic Protein 2; Calcium; Cell Adhesion; Cell Proliferation; Cell Shape; Chelating Agents; Chitosan; Coated Materials, Biocompatible; Dental Implants; Drug Carriers; Durapatite; Gene Expression Regulation; Humans; Jurkat Cells; Mesenchymal Stem Cells; Nanoparticles; Nanotechnology; Osteogenesis; Prosthesis Design; Surface Properties; Tissue Scaffolds; Titanium | 2013 |
Development and characterization of a gastroretentive dosage form composed of chitosan and hydroxyethyl cellulose for alendronate.
Topics: Alendronate; Bone Density Conservation Agents; Cellulose; Chitosan; Solubility; Tablets | 2014 |
Emulsion cross-linked chitosan/nanohydroxyapatite microspheres for controlled release of alendronate.
Topics: Alendronate; Animals; Bone Density Conservation Agents; Capsules; Cell Differentiation; Cells, Cultured; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Durapatite; Emulsions; Nanoparticles; Osteoblasts; Osteogenesis; Rabbits; Stem Cells | 2014 |
Bioabsorbable bone plates enabled with local, sustained delivery of alendronate for bone regeneration.
Topics: Absorbable Implants; Alendronate; Animals; Bone Density Conservation Agents; Bone Plates; Bone Regeneration; Cell Line; Cell Line, Tumor; Chitosan; Delayed-Action Preparations; Drug Liberation; Humans; Male; Mice; Rats, Sprague-Dawley; Skull | 2016 |
Reconstruction of Large-scale Defects with a Novel Hybrid Scaffold Made from Poly(L-lactic acid)/Nanohydroxyapatite/Alendronate-loaded Chitosan Microsphere: in vitro and in vivo Studies.
Topics: Alendronate; Animals; Bone Regeneration; Bone Substitutes; Cells, Cultured; Chitosan; Drug Delivery Systems; Durapatite; In Vitro Techniques; Lactic Acid; Microspheres; Osteogenesis; Rabbits; Tissue Engineering; Tissue Scaffolds | 2017 |
Microfluidic fabrication of alendronate-loaded chitosan nanoparticles for enhanced osteogenic differentiation of stem cells.
Topics: Adipocytes; Alendronate; Animals; Bone and Bones; Bone Regeneration; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chitosan; Humans; Mesenchymal Stem Cells; Microfluidics; Nanoparticles; Osteogenesis; Stem Cells; Tissue Engineering; Tissue Scaffolds | 2020 |
Ultrasound-assisted transdermal delivery of alendronate for the treatment of osteoporosis.
Topics: Administration, Cutaneous; Alendronate; Animals; Biological Availability; Bone Density Conservation Agents; Calcium; Chitosan; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Male; Nanoparticles; Osteoporosis; Particle Size; Permeability; Rats; Rats, Sprague-Dawley; Skin; Transdermal Patch; Treatment Outcome; Ultrasonic Waves | 2020 |
Alendronate crosslinked chitosan/polycaprolactone scaffold for bone defects repairing.
Topics: Alendronate; Animals; Bone Regeneration; Cell Differentiation; Chitosan; Osteogenesis; Polyesters; Rats; Rats, Sprague-Dawley; Tissue Engineering; Tissue Scaffolds; X-Ray Microtomography | 2022 |